Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New blood test for small redworms in horses announced
The test will be available to horse owners from September 2019.

Test will be available to horse owners from September 2019

A new blood test to help diagnose small redworms in horses, including encysted larvae, has been developed by scientists at the Moredun Research Institute (MRI).

The test will be available to horse owners from September 2019 following extensive research and will be launched by commercial partner, Austin Davis Biologics (ADB).


Professor Jacqui Matthews, who led the Matthews research group at MRI, said: “It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses.

“The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."

MRI business development manager Rhona Macdonald added: “We are delighted that the research has led to the development of a new blood test to help diagnose small redworms in horses and that the test is now available through Austin Davis Biologics.”


The new service provision marks the first phase in developing the blood test for commercialisation. 


Dr Corrine Austin of ADB said: “We are thrilled to be making this test available to horse owners after extensive research has been conducted to achieve high accuracy. ADB are now developing laboratory ELISA [enzyme-linked immunosorbent assay] kits to enable independent veterinary laboratories to conduct blood testing. 


“These kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now.”

Veterinary practices interested in the diagnostic test service can register their interest at info@austindavis.co.uk

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.